Inventor · disambiguated record
Andrew David Warren
Also filed as: WARREN ANDREW · WARREN ANDREW D · WARREN ANDREW DAVID
8 granted patents·6 pending applications·30 citations·filing 2014–2022
83Inventor score
Top patents by PatentIndex Score
14 records- 0191US11448643B2Methods to specifically profile protease activity at lymph nodesMASSACHUSETTS INST TECHNOLOGY·Filed 2017·Granted Sep 20, 2022·5 cites·16 claims
- 0291US10527619B2Affinity-based detection of ligand-encoded synthetic biomarkersMASSACHUSETTS INST TECHNOLOGY·Filed 2014·Granted Jan 7, 2020·12 cites·22 claims
- 0389US11519905B2Methods to spatially profile protease activity in tissue and sectionsMASSACHUSETTS INST TECHNOLOGY·Filed 2018·Granted Dec 6, 2022·5 cites·21 claims
- 0489US11028425B2Diagnosis and monitoring of liver diseaseGLYMPSE BIO INC·Filed 2019·Granted Jun 8, 2021·4 cites·9 claims
- 0586US11732009B2Activity sensor with tunable analyteGLYMPSE BIO INC·Filed 2019·Granted Aug 22, 2023·3 cites·12 claims
- 0680US11977074B2Affinity-based detection of ligand-encoded synthetic biomarkersMASSACHUSETTS INST TECHNOLOGY·Filed 2019·Granted May 7, 2024·1 cites·20 claims
- 0775US12320801B2Methods to spatially profile protease activity in tissue and sectionsMASSACHUSETTS INST TECHNOLOGY·Filed 2022·Granted Jun 3, 2025·0 cites·20 claims
- 0872US2023040528A1Methods to specifically profile protease activity at lymph nodesMASSACHUSETTS INST TECHNOLOGY·Filed 2022·Application pending·0 cites
- 0962US2022090162A1Diagnosis and monitoring of liver diseaseGLYMPSE BIO INC·Filed 2021·Application pending·0 cites
- 1056US12173349B2Lung protease nanosensors and uses thereofMASSACHUSETTS INST TECHNOLOGY·Filed 2019·Granted Dec 24, 2024·0 cites·20 claims
- 1149US2020246489A1Detecting architectural remodelling in cells, extracellular matrix, and the tissue microenvironmentGLYMPSE BIO INC·Filed 2020·Application pending·0 cites
- 1248US2019376115A1Activity sensor designGLYMPSE BIO INC·Filed 2019·Application pending·0 cites
- 1347US2020249229A1Bodily processing of activity sensorsGLYMPSE BIO INC·Filed 2020·Application pending·0 cites
- 1445US2020245926A1Compositions and methods for monitoring progression and regression of disease in patients in response to therapyGLYMPSE BIO INC·Filed 2019·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Andrew David Warren files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →